Phoenix Biotech Acquisition Corp.
NASDAQ:PBAX
5.85 (USD) • At close February 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2022 | 2021 | |
|---|---|---|---|
| Revenue
| 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 |
| Gross Profit
| 0 | 0.255 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 |
| Reseach & Development Expenses
| 7.08 | 0 | 0 |
| General & Administrative Expenses
| 9.118 | 2.841 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0.251 |
| SG&A
| 9.118 | 2.841 | 0.252 |
| Other Expenses
| 0 | 0.064 | -0.08 |
| Operating Expenses
| 16.198 | 2.905 | 0.332 |
| Operating Income
| -16.198 | -0.003 | -0.332 |
| Operating Income Ratio
| 0 | 0 | 0 |
| Total Other Income Expenses Net
| 5.109 | 0.003 | -0 |
| Income Before Tax
| -11.089 | -0.069 | -0.332 |
| Income Before Tax Ratio
| 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.599 | -0.017 |
| Net Income
| -11.089 | -0.668 | -0.316 |
| Net Income Ratio
| 0 | 0 | 0 |
| EPS
| -0.22 | -0.01 | -0.005 |
| EPS Diluted
| -0.22 | -0.01 | -0.005 |
| EBITDA
| -16.198 | -5.742 | -0.332 |
| EBITDA Ratio
| 0 | 0 | 0 |